PROPUBLICA Fearless Reporting for an Informed Society — Join Us.
DONATE
Skip to content
ProPublica Donate
ProPublica Donate

Rogosin Institute Inc

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Health — General and Rehabilitative / Research Institutes and/or Public Policy Analysis (NTEE)

Donations to this organization are tax deductible.

Summary charts: organization finances over time

Revenue
$118M (2023)

Expenses
$123M (2023)

Total Assets
$117M (2023)

Total Liabilities
$101M (2023)

Source: Form 990 tax filings from 2011 to 2023

Tax Filings and Audits by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Audits are required to be submitted by nonprofit organizations that spend $750,000 or more in federal grant money in a fiscal year. "Single audits" look at the entire organization's finances and compliance, while other audits are program specific. Nonprofit Explorer has PDFs of audits for some nonprofits for fiscal year 2015 and later. Audit data is from the Federal Audit Clearinghouse.

Fiscal Year Ending Dec.
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$118,417,253
Expenses
$122,658,383
Net Income
-$4,241,130
Net Assets
$16,043,473
Notable Sources of Revenue Percent of Total Revenue
Contributions $4,297,607
3.6%
Program Services $111,658,396
94.3%
Investment Income $294,494
0.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising -$65,576
Sales of Assets -$367,332
Net Inventory Sales $0
Other Revenue $2,599,664
2.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $3,272,227
2.7%
Professional Fundraising Fees $0
Other Salaries and Wages $52,756,950
43.0%
Assets/Debt
Total Assets $116,787,782
Total Liabilities $100,744,309
Net Assets $16,043,473
Compensation
Key Employees and Officers Compensation Related Other
Stuart D Saal (Vp Nephrology/Consultive Svcs) $577,581 $0 $54,809
Bruce R Gordon (Evp/Clinical Service & Strategy) $488,756 $0 $24,458
Jeffrey Silberzweig (Vp Nephrology/Dialysis & Cmo) $479,239 $0 $24,990
Jun B Lee (Physician) $462,240 $255,900 $67,879
Allyson Z Pifko (Evp/Coo) $461,801 $0 $23,681
Alan S Perlman (Physician) $432,786 $0 $54,306
Andrew Bohmart (Physician) $425,987 $0 $18,829
Jay Lakkis (Physician) $419,484 $0 $33,211
Vijay K Sharma (Lab Director) $416,933 $0 $23,417
Choli Hortono (Physician) $382,524 $0 $56,395
Daniel M Levine (Vp Info. Tech./Cio) $341,225 $0 $46,213
Allen Herman (Former Key Employee) $242,752 $0 $32,691
Rex A Friedlander (Former Key Employee) $233,387 $0 $10,598
Diana Decolongon (Hr Director) $206,438 $0 $21,153
Susan Spiegel (Vp Develop & Public Affair) $75,782 $0 $5,752
Karen Westervelt (Vice Chair) $0 $1,466,445 $66,392
Miriam Rike (Treasurer) $0 $1,161,825 $67,757
Robert Min (Chariman) $0 $0 $0
Shaun E Smith (Secretary) $0 $1,710,183 $61,522
Anne Alexis Cote Taylor (Director) $0 $0 $0
Brian K Regan (Director) $0 $553,886 $79,670
Charlotte M Ford (Director) $0 $0 $0
Claudia Rosen (Director) $0 $820,512 $48,415
Fred H Mermelstein (Director) $0 $0 $0
Ingird Magean Bell (Director (Thru 6/2023)) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$116,515,923
Expenses
$123,934,554
Net Income
-$7,418,631
Net Assets
$6,836,280
Notable Sources of Revenue Percent of Total Revenue
Contributions $5,282,773
4.5%
Program Services $107,301,973
92.1%
Investment Income $1,534,453
1.3%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising -$2,632
Sales of Assets $681,222
0.6%
Net Inventory Sales $0
Other Revenue $1,718,134
1.5%
Notable Expenses Percent of Total Expenses
Executive Compensation $3,239,254
2.6%
Professional Fundraising Fees $0
Other Salaries and Wages $52,087,669
42.0%
Assets/Debt
Total Assets $117,935,683
Total Liabilities $111,099,403
Net Assets $6,836,280
Compensation
Key Employees and Officers Compensation Related Other
Stuart D Saal (Vp Nephrology/Consultive Svcs) $564,732 $0 $54,509
Bruce R Gordon (Evp/Clinical Service & Strategy) $474,564 $0 $23,601
Jeffrey Silberzweig (Vp Nephrology/Dialysis & Cmo) $471,086 $0 $24,052
Jun B Lee (Physician) $468,941 $309,476 $66,517
Alan S Perlman (Physician) $426,068 $0 $52,037
Allyson Z Pifko (Evp/Coo) $402,770 $0 $22,453
Jay Lakkis (Physician) $402,391 $0 $22,385
Vijay K Sharma (Lab Director) $399,624 $0 $21,129
Andrew Bohmart (Physician) $395,234 $0 $18,164
Choli Hortono (Physician) $380,776 $0 $53,892
Daniel M Levine (Vp Info. Tech./Cio) $330,672 $0 $46,072
Allen Herman (Former Key Employee) $235,733 $0 $32,215
Rex A Friedlander (Former Key Employee) $226,558 $0 $10,206
Diana Decolongon (Hr Director) $200,408 $0 $20,309
Susan Spiegel (Vp Develop & Public Affair) $154,192 $0 $29,082
Diane Morris (Former Key Employee) $102,875 $0 $9,929
Karen Westervelt (Vice Chair) $0 $1,398,488 $61,767
Miriam Rike (Treasurer) $0 $878,190 $39,664
Robert Min (Chariman) $0 $0 $0
Shaun E Smith (Secretary) $0 $1,585,058 $54,722
Anne Alexis Cote Taylor (Director) $0 $0 $0
Anthony Hollenberg (Director (Thru 9/2022)) $0 $0 $0
Brian K Regan (Director) $0 $597,032 $68,694
Charlotte M Ford (Director) $0 $0 $0
Claudia Rosen (Director) $0 $671,040 $35,475

Document Links

Fiscal Year Ending Dec.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$118,085,739
Expenses
$119,698,006
Net Income
-$1,612,267
Net Assets
$18,506,841
Notable Sources of Revenue Percent of Total Revenue
Contributions $6,332,285
5.4%
Program Services $107,909,923
91.4%
Investment Income $2,209,000
1.9%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $131,845
0.1%
Net Inventory Sales $0
Other Revenue $1,502,686
1.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $5,151,449
4.3%
Professional Fundraising Fees $0
Other Salaries and Wages $48,504,110
40.5%
Assets/Debt
Total Assets $82,482,762
Total Liabilities $63,975,921
Net Assets $18,506,841
Compensation
Key Employees and Officers Compensation Related Other
Stuart D Saal Md (Vp Nephrology/Consultive Svcs) $534,184 $0 $55,823
Bruce R Gordon Md (Evp/Strategy) $466,930 $0 $40,993
Jeffrey Silberzweig Md (Vp Dialysis Services/Physician) $455,657 $0 $45,412
Vijay K Sharma (Lab Director) $375,651 $0 $43,585
Allyson Z Pifko Rn (Evp/Chief Operating Officer) $350,097 $0 $41,461
Alan S Perlman (Physician) $349,175 $0 $55,116
Daniel M Levine Phd (Vp Information Technology) $327,818 $0 $35,425
Choli Hartono (Physician) $308,811 $0 $48,386
Jun B Lee (Physician) $300,779 $0 $41,763
Andrew Bohmart (Physician) $293,550 $0 $38,826
Frank Liu (Physician) $273,726 $0 $31,607
Allen Herman (Regional Administrator) $238,359 $0 $26,077
Thomas S Parker Phd (Vp Biochemical Research) $223,923 $0 $33,115
Rex A Friedlander (Lab & Info System Supervisor) $214,677 $0 $35,898
Diane Morris (Director Of Nursing) $207,960 $0 $39,661
Diana Decolongon (Human Resources Director) $200,339 $0 $21,955
Susan Spiegel (Vp Develop & Public Affair) $158,463 $0 $36,342
John Cl Wang Md Phd (Vp Clinical Nephrology) $33,333 $0 $0
Kurt H Stenzel Md (Director) $4,167 $0 $0
Josh Abramowitz (Director) $0 $0 $0
Craig Albanese Md Mba (Director) $0 $0 $0
Daniel Barchi (Director) $0 $2,248,951 $67,019
Ingird Magean Bell (Director) $0 $0 $0
Charlotte M Ford (Director) $0 $0 $0
Robert Fried Cpa (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$114,237,768
Expenses
$118,803,384
Net Income
-$4,565,616
Net Assets
$20,352,175
Notable Sources of Revenue Percent of Total Revenue
Contributions $3,545,787
3.1%
Program Services $108,215,611
94.7%
Investment Income $550,069
0.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $210,787
0.2%
Net Inventory Sales $0
Other Revenue $1,715,514
1.5%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,223,151
3.6%
Professional Fundraising Fees $0
Other Salaries and Wages $49,284,324
41.5%
Assets/Debt
Total Assets $90,432,810
Total Liabilities $70,080,635
Net Assets $20,352,175
Compensation
Key Employees and Officers Compensation Related Other
Stuart D Saal Md (Vp Nephrology/Consultive Svcs) $510,665 $0 $50,067
Bruce R Gordon Md (Evp/Strategy) $446,372 $0 $18,939
Jeffrey Silberzweig Md (Vp Dialysis Services/Physician) $435,596 $0 $18,834
Vijay K Sharma (Lab Director) $359,113 $0 $16,206
Allyson Z Pifko Rn (Evp/Chief Operating Officer) $334,684 $0 $15,020
Daniel M Levine Phd (Vp Information Technology) $313,385 $0 $57,910
Jon D Blumenfeld (Physician) $311,803 $0 $13,232
Leif H Oxburgh (Scientific Director/Vp For Basic And Clinical) $304,258 $0 $18,814
Lawrence Gazda (Director Xenia Division) $287,985 $0 $49,329
Choli Hartono (Physician) $287,523 $0 $49,112
Alan S Perlman (Physician) $282,600 $0 $48,815
Jun B Lee (Physician) $279,844 $0 $40,827
Gail Frumkin (Co Director Of Dialysis/Physician) $277,798 $0 $42,959
Allen Herman (Regional Administrator) $236,636 $0 $33,915
Thomas S Parker Phd (Vp Biochemical Research) $214,065 $0 $38,067
Diane Morris (Director Of Nursing) $198,026 $0 $23,112
Diana Decolongon (Human Resources Director) $191,519 $0 $8,565
Rex A Friedlander (Lab & Info System Supervisor) $181,817 $0 $8,662
Susan Spiegel (Vp Develop & Public Affair) $151,487 $0 $30,159
John Cl Wang Md Phd (Vp Clinical Nephrology) $141,667 $0 $0
Barry H Smith Md Phd (Former President) $131,103 $0 $12,998
Kurt H Stenzel Md (Director) $50,000 $0 $0
James Fabian Esq (Co Counsel) $33,333 $0 $0
Josh Abramowitz (Director) $0 $0 $0
Daniel Barchi (Director) $0 $2,108,969 $63,455

Document Links

Fiscal Year Ending Dec.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$110,922,475
Expenses
$114,249,541
Net Income
-$3,327,066
Net Assets
$28,296,326
Notable Sources of Revenue Percent of Total Revenue
Contributions $1,989,632
1.8%
Program Services $104,218,385
94.0%
Investment Income $304,200
0.3%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $16,854
0.0%
Sales of Assets $56,235
0.1%
Net Inventory Sales $0
Other Revenue $4,337,169
3.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $5,682,194
5.0%
Professional Fundraising Fees $0
Other Salaries and Wages $42,865,230
37.5%
Assets/Debt
Total Assets $84,015,491
Total Liabilities $55,719,165
Net Assets $28,296,326
Compensation
Key Employees and Officers Compensation Related Other
Stuart D Saal Md (Vp Nephrology/Consultive Svcs) $545,626 $0 $29,099
Barry H Smith Md Phd (President) $537,240 $0 $30,451
Bruce R Gordon Md (Evp Clinical/Strategy) $437,086 $0 $18,399
Jeffrey Silberzweig Md (Vp Dialysis Services/Physician) $425,854 $0 $18,533
Alan S Perlman (Physician) $392,730 $0 $21,283
Vijay K Sharma (Lab Director) $368,349 $0 $28,558
David Serur (Physician) $352,395 $0 $14,322
Jun B Lee (Physician) $341,212 $0 $15,972
Frank Liu (Physician) $340,820 $0 $11,763
Patricia Antoniello (Dialysis Administrator) $337,396 $0 $4,100
Allyson Pifko (Chief Operating Officer/Cco) $308,158 $0 $13,853
Jon D Blumenfeld (Physician) $306,039 $0 $12,855
Daniel M Levine Phd (Vp Information Technology) $293,983 $0 $24,790
Lawrence Gazda (Director Xenia Division) $285,264 $0 $20,685
Allen Herman (Regional Administrator) $222,732 $0 $15,103
Pamela Hoyt Hudson Rn (Vp Health Action & Policy) $219,573 $0 $14,098
Thomas S Parker Phd (Vp Biochemical Research) $209,528 $0 $17,458
Diane Morris (Director Of Nursing) $192,077 $0 $12,203
Rex A Friedlander (Lab & Info System Supervisor) $187,793 $0 $8,994
Diana Decolongon (Human Resources Director) $187,765 $0 $8,333
John Cl Wang Md Phd (Vp Clinical Nephrology) $160,000 $0 $0
Susan Spiegel (Vp Develop & Public Affair) $148,218 $0 $11,786
Kurt H Stenzel Md (Director) $50,000 $0 $0
James Fabian Esq (Co Counsel) $50,000 $0 $0
Arnold H Tracy Esq (Director & Co Counsel) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$102,030,839
Expenses
$105,745,432
Net Income
-$3,714,593
Net Assets
$30,935,360
Notable Sources of Revenue Percent of Total Revenue
Contributions $2,170,761
2.1%
Program Services $96,812,427
94.9%
Investment Income $923,195
0.9%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $270,346
0.3%
Sales of Assets $1,239,358
1.2%
Net Inventory Sales $0
Other Revenue $614,752
0.6%
Notable Expenses Percent of Total Expenses
Executive Compensation $5,064,048
4.8%
Professional Fundraising Fees $0
Other Salaries and Wages $38,234,872
36.2%
Assets/Debt
Total Assets $81,135,504
Total Liabilities $50,200,144
Net Assets $30,935,360
Compensation
Key Employees and Officers Compensation Related Other
Barry H Smith Md Phd (President/Ceo) $512,874 $0 $41,155
Stuart D Saal Md (Vp Nephrology/Consultive Svcs) $467,331 $0 $37,531
Jeffrey Silberzweig Md (Vp Dialysis Services) $422,856 $0 $16,516
Bruce R Gordon Md (Sr. Vp Chief Operating Officer) $417,924 $0 $16,694
Vijay K Sharma (Lab Director) $344,593 $0 $45,984
Frank Liu (Physician) $343,597 $0 $9,922
David Serur (Physician) $339,886 $0 $12,403
Alan S Perlman (Physician) $325,384 $0 $39,178
Choli Hartono (Physician) $307,413 $0 $37,734
Jun B Lee (Physician) $301,825 $0 $23,741
Jon D Blumenfeld (Physician) $294,942 $0 $11,822
Lawrence Gazda (Director Xenia Division) $269,124 $0 $39,537
Daniel M Levine Phd (Vp Information Technology) $245,196 $0 $41,933
Allyson Pifko (Vp Operations/Compliance) $221,288 $0 $9,041
Allen Herman (Regional Administrator) $211,157 $0 $8,633
Pamela Hoyt Hudson Rn (Vp Health Action & Policy) $206,249 $0 $19,103
Thomas S Parker Phd (Vp Biochemical Research) $195,402 $0 $28,465
Diane Morris (Director Of Nursing) $179,495 $0 $17,962
Rex A Friedlander (Lab & Info System Supervisor) $179,294 $0 $7,162
Diana Decolongon (Human Resources Director) $169,384 $0 $27,457
John Cl Wang Md Phd (Vp Clinical Nephrology) $166,107 $0 $0
Susan Spiegel (Vp Develop & Public Affair) $131,928 $0 $28,100
Kurt H Stenzel Md (Director) $50,000 $0 $0
James Fabian Esq (Co Counsel) $50,000 $0 $0
Arnold H Tracy Esq (Director & Co Counsel) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$99,419,923
Expenses
$101,212,916
Net Income
-$1,792,993
Net Assets
$35,704,359
Notable Sources of Revenue Percent of Total Revenue
Contributions $7,512,012
7.6%
Program Services $91,000,122
91.5%
Investment Income $1,209,872
1.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising -$109,355
Sales of Assets $172,391
0.2%
Net Inventory Sales $0
Other Revenue -$365,119
Notable Expenses Percent of Total Expenses
Executive Compensation $4,471,300
4.4%
Professional Fundraising Fees $0
Other Salaries and Wages $38,036,763
37.6%
Assets/Debt
Total Assets $81,086,523
Total Liabilities $45,382,164
Net Assets $35,704,359
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Barry H Smith (President/Ceo) $500,258 $0 $44,213
Jeffery Silberzweig Md (Vp Dialysis Services) $405,455 $0 $18,849
Stuart D Saal Md (Vp Nephrology/Consultive Svcs) $398,258 $0 $17,627
Bruce R Gordon Md (Sr. Vp Chief Operating Officer) $388,887 $0 $18,664
Sharma Vijay K (Lab Director) $340,284 $0 $45,855
Serur David (Physician) $334,515 $0 $13,307
Perlman Alan S (Physician) $323,218 $0 $48,082
Liu Frank (Physician) $321,984 $0 $19,620
Lee Jun B (Physician) $309,379 $0 $32,225
Hartono Choli (Physician) $288,725 $0 $44,956
Blumenfeld Jon D (Physician) $287,293 $0 $15,815
Gazda Lawrence (Director Xenia Division) $267,410 $0 $41,779
Daniel M Levine Phd (Vp Information Technology) $239,208 $0 $49,437
John Cl Wang Md Phd (Vp Clinical Nephrology) $210,826 $0 $29,151
Pamela Hoyt Hudson Rn (Vp Health Action & Policy) $196,220 $0 $28,585
Allyson Pifko (Vp Operations/Compliance) $195,721 $0 $13,070
Thomas S Parker Phd (Vp Biochemical Research) $190,481 $0 $29,332
Decolongon Diana (Director) $168,501 $0 $7,139
Susan Spiegel (Vp Develop & Public Affair) $127,788 $0 $40,193
Kurt H Stenzel Md (Director) $75,000 $0 $0
James Fabian Esq (Co Counsel) $50,000 $0 $0
Arnold H Tracy Esq (Director & Co Counsel) $30,000 $0 $0
Anne Alexis Cote Taylor (Secretary To The Board) $0 $0 $0
Charles Rizzo (Director) $0 $0 $0
Charlotte M Ford (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$91,933,179
Expenses
$95,425,504
Net Income
-$3,492,325
Net Assets
$36,247,534
Notable Sources of Revenue Percent of Total Revenue
Contributions $3,094,642
3.4%
Program Services $89,174,194
97.0%
Investment Income $179,405
0.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising -$161,242
Sales of Assets $41,659
0.0%
Net Inventory Sales $0
Other Revenue -$395,479
Notable Expenses Percent of Total Expenses
Executive Compensation $5,253,638
5.5%
Professional Fundraising Fees $0
Other Salaries and Wages $36,062,315
37.8%
Assets/Debt
Total Assets $73,711,582
Total Liabilities $37,464,048
Net Assets $36,247,534
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Barry H Smith Md Phd (President/Ceo) $545,314 $0 $42,920
Bruce R Gordon Md (Chief Operations Officer) $377,577 $0 $17,834
Jeffery Silberzweig Md (Vp Dialysis Services) $374,165 $0 $16,167
Stuart D Saal Md (Vp Nephrology) $363,612 $0 $16,281
Sharma Vijay K (Lab Director) $330,276 $0 $47,915
Liu Frank (Physician) $308,857 $0 $18,514
Serur David (Physician (Non Mgr)) $297,335 $0 $11,184
John Cl Wang Md Phd (Vp Clinical Nephrology) $292,742 $0 $48,868
Lee Jun B (Physician (Non Mgr)) $288,584 $0 $34,110
Perlman Alan S (Physician) $288,424 $0 $48,234
Hartono Choli (Physician) $280,006 $0 $46,253
Blumenfeld Jon D (Physician) $279,002 $0 $14,884
Gazda Lawrence (Director) $254,543 $0 $41,672
Daniel M Levine Phd (Vp Information Technology) $232,099 $0 $49,926
Herman Allen (Regional Administrator) $202,618 $0 $28,409
Pamela Hoyt Hudson Rn (Vp Health Action & Policy) $189,560 $0 $25,588
Allyson Pifko (Vp Operations/Compliance) $189,220 $0 $12,802
Thomas S Parker Phd (Vp Biochemical Research) $184,760 $0 $36,996
Friedlander Rex A (Laboratory & Information Syste) $169,879 $0 $7,172
Morris Diane (Director Of Nursing Dialysis) $168,454 $0 $22,708
Decolongon Diana (Director) $163,858 $0 $6,443
Antoniello Patricia (Administrator) $156,045 $0 $19,591
Susan Spiegel (Vp Develop & Public Affair) $125,720 $0 $38,470
Kurt H Stenzel Md (Director) $80,192 $0 $0
James Fabian Esq (Co Counsel) $49,359 $0 $0

Document Links

Fiscal Year Ending Dec.
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$96,010,909
Expenses
$95,458,190
Net Income
$552,719
Net Assets
$39,650,295
Notable Sources of Revenue Percent of Total Revenue
Contributions $4,949,895
5.2%
Program Services $90,365,268
94.1%
Investment Income $626,143
0.7%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising -$166,805
Sales of Assets $236,408
0.2%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $5,803,681
6.1%
Professional Fundraising Fees $20,000
0.0%
Other Salaries and Wages $34,237,766
35.9%
Assets/Debt
Total Assets $77,808,618
Total Liabilities $38,158,323
Net Assets $39,650,295
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Barry H Smith Md Phd (President/Ceo) $408,039 $0 $34,059
Jeffery Silberzweig Md (Vp Dialysis Services) $402,398 $0 $12,753
Bruce R Gordon Md (Chief Operations Officer) $380,638 $0 $14,354
Stuart D Saal Md (Vp Nephrology & Special Consul) $365,218 $0 $12,274
Jun B Lee (Physician) $319,922 $0 $29,809
Vijay K Sharma (Lab Director) $319,534 $0 $46,967
Frank Liu (Physician) $311,997 $0 $16,927
David Serur (Physician) $299,170 $0 $8,567
John C Wang Md Phd (Vp Outpatient Services) $295,592 $0 $43,168
Jon D Blumenfeld (Physician) $281,070 $0 $12,084
Choli Hartono (Physician) $279,117 $0 $42,745
Alan S Perlman (Physician) $278,591 $0 $42,562
Lawrence Gazda (Director) $256,851 $0 $36,925
Jonathan Lorch Md (Vp For Dialysis Svcs/Physician) $239,708 $0 $30,223
Daniel M Levine Phd (Chief Information Officer) $237,887 $0 $45,251
Maryanne Greenfield (Vp Of Institutional Adv.) $210,252 $0 $40,823
Allen Herman (Regional Administrator) $190,187 $0 $26,457
Allyson Pifko (Vp Of Operations) $189,849 $0 $9,494
Thomas S Parker Phd (Vp Biochemical Research) $184,855 $0 $37,071
Camille Romain (Director) $176,192 $0 $23,291
Nancy Kong (Controller) $172,190 $0 $9,127
Diane Morris (Director Of Nursing Dialysis) $170,070 $0 $17,987
Rex A Friedlander (Laboratory & Information Syste) $163,833 $0 $7,662
Diana Decolongon (Director) $157,569 $0 $6,122
Patricia Antoniello (Administrator) $155,858 $0 $20,265

Document Links

Fiscal Year Ending Dec.
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$100,085,266
Expenses
$88,904,383
Net Income
$11,180,883
Net Assets
$39,941,266
Notable Sources of Revenue Percent of Total Revenue
Contributions $9,657,518
9.6%
Program Services $89,499,432
89.4%
Investment Income $850,836
0.9%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising -$228,820
Sales of Assets $306,300
0.3%
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $7,050,819
7.9%
Professional Fundraising Fees $0
Other Salaries and Wages $29,795,147
33.5%
Assets/Debt
Total Assets $72,271,859
Total Liabilities $32,330,593
Net Assets $39,941,266
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Barry H Smith Md Phd (President/Ceo) $381,125 $0 $38,650
Jeffery Silberzweig Md (Vp Hospital Relations) $356,512 $0 $45,359
Bruce R Gordon Md (Chief Operations Officer) $341,559 $0 $19,641
Stuart D Saal Md (Vp Transplantation) $336,847 $0 $17,985
Vijay K Sharma (Lab Director) $297,384 $0 $43,008
David Serur Md (Physician) $282,229 $0 $13,155
John C Wang Md Phd (Vp Clinical Nephrology) $276,907 $0 $44,931
Frank Liu (Physician) $276,681 $0 $22,829
Jun B Lee (Physician) $268,743 $0 $31,516
Jon Blumenfeld Md (Physician) $254,619 $0 $15,037
Alan S Perlman (Physician) $248,939 $0 $43,349
Choli Hartono (Physician) $243,442 $0 $43,294
Lawrence Gazda (Director) $240,643 $0 $38,370
Jonathan Lorch Md (Vp For Dialysis Services) $226,431 $0 $32,069
Daniel M Levine Phd (Vp Clinical Biochemistry) $223,335 $0 $42,936
Gail Frumkin Md (Dialysis Co Director/Physician) $213,670 $0 $40,701
James Chevalier (Physician) $207,333 $0 $11,594
Herman Allen (Administrator) $196,902 $0 $29,763
Maryanne Greenfield (Vp Of Institutional Adv.) $194,956 $0 $42,276
Miriam H Chung (Physician) $187,114 $0 $19,418
Karunakaran Menon (Lab Manager) $183,028 $0 $9,467
Thomas S Parker Phd (Vp Biochemical Research) $171,908 $0 $37,397
Nathaniel Berman (Physician) $169,765 $0 $36,394
Allyson Pifko (Director Of Operations) $169,066 $0 $14,786
Camille Romain (Director Bio Med) $165,369 $0 $24,642

Document Links

Fiscal Year Ending Dec.
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$72,998,108
Expenses
$69,178,329
Net Income
$3,819,779
Net Assets
$29,419,025
Notable Sources of Revenue Percent of Total Revenue
Contributions $4,658,819
6.4%
Program Services $66,963,754
91.7%
Investment Income $1,599,887
2.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising -$224,352
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $6,772,432
9.8%
Professional Fundraising Fees $0
Other Salaries and Wages $21,641,412
31.3%
Assets/Debt
Total Assets $58,262,337
Total Liabilities $28,843,312
Net Assets $29,419,025
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Barry H Smith Md Phd (President/Ceo) $374,149 $0 $18,863
Jeffery Silberzweig Md (Vp Hospital Relations) $319,638 $0 $21,702
Bruce R Gordon Md (Chief Operations Officer) $314,487 $0 $6,873
Stuart D Saal Md (Vp Transplantation) $313,198 $0 $6,658
Vijay K Sharma (Lab Director) $296,243 $0 $22,512
David Serur Md (Physician) $277,664 $0 $5,426
John C Wang Md (Vp Clinical Nephrology) $271,266 $0 $22,325
Jun B Lee (Physician) $250,454 $0 $14,266
Frank Liu (Physician) $240,273 $0 $4,760
Jon Blumenfeld Md (Physician) $237,402 $0 $5,204
Jonathan Lorch Md (Vp For Dialysis Services) $236,518 $0 $15,526
Lawrence Gazda (Director) $235,704 $0 $21,737
Alan S Perlman (Physician) $233,356 $0 $20,584
Choli Hartono (Physician) $224,764 $0 $19,848
Gail Frumkin Md (Dialsys Co Director/Physician) $208,199 $0 $27,777
Daniel M Levine Ph D (Vp Clinical Biochemistry) $201,608 $0 $20,697
James Chevalier (Physician) $199,579 $0 $4,406
Miriam H Chung (Physician) $198,562 $0 $9,008
John F Sullivan Md (Dialysis Director) $192,175 $0 $14,981
Maryanne Greenfield (Vp Of Institutional Adv.) $191,104 $0 $16,683
Roxana M Bologa (Physician) $185,962 $0 $14,814
Karunakaran Menon (Lab Manager) $170,078 $0 $3,620
Thomas S Parker Phd (Vp Biochemical Research) $169,230 $0 $19,575
Camille Romain (Director Bio Med) $161,876 $0 $14,249
Mary E Mescher (Manager) $158,338 $0 $5,417

Document Links

Fiscal Year Ending Dec.
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$71,913,456
Expenses
$67,385,439
Net Income
$4,528,017
Net Assets
$24,573,128
Notable Sources of Revenue Percent of Total Revenue
Contributions $4,220,150
5.9%
Program Services $67,035,933
93.2%
Investment Income $828,962
1.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising -$171,589
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $6,743,073
10.0%
Professional Fundraising Fees $0
Other Salaries and Wages $20,353,426
30.2%
Assets/Debt
Total Assets $53,441,870
Total Liabilities $28,868,742
Net Assets $24,573,128

Document Links

Fiscal Year Ending Dec.
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$64,121,769
Expenses
$66,166,323
Net Income
-$2,044,554
Net Assets
$19,916,295
Notable Sources of Revenue Percent of Total Revenue
Contributions $3,359,848
5.2%
Program Services $44,593,999
69.5%
Investment Income $1,118,488
1.7%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising -$230,014
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $15,279,448
23.8%
Notable Expenses Percent of Total Expenses
Executive Compensation $6,859,245
10.4%
Professional Fundraising Fees $0
Other Salaries and Wages $19,094,884
28.9%
Assets/Debt
Total Assets $46,637,724
Total Liabilities $26,721,429
Net Assets $19,916,295

Document Links

Fiscal Year Ending Dec.
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2009

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2008

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2007

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2006

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2005

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2004

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2003

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2002

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2001

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »